Regulation of autophagy and mitochondrial permeability by target of rapamycin complex 2
Regulation of autophagy and mitochondrial permeability by target of rapamycin complex 2
批准号:
10241881
负责人:
ALEXANDER A SOUKAS
金额:
$64.91万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2022-08-31
关键词:
AgingAutoimmune ProcessAutophagocytosisBiological ModelsCaenorhabditis elegansCell physiologyCellsComplexDataDefectDiseaseEatingEukaryotic CellFRAP1 geneFamilyFunctional disorderGenesGeneticGenetic TranscriptionGlucocorticoidsGoalsGrowthGrowth FactorHealthHealth PromotionHumanInflammatoryInterventionLeadLinkLiverLongevityMammalsMetabolicMetabolismMitochondriaMolecularMorbidity - disease rateMusMutationNerve DegenerationNeurodegenerative DisordersOrganellesOrganismPathway interactionsPermeabilityPhosphotransferasesPredispositionPremature aging syndromeProcessProtein KinaseProteomeProteomicsPublic HealthRegulationReperfusion InjuryReproductionResearchResistanceSerumSignal PathwaySignal TransductionSirolimusStressTestingWorkbasecombatdesigngenetic regulatory proteinhealthy agingknockout animalliver ischemialoss of function mutationmacromoleculemitochondrial permeability transition poremutantneoplasticnew therapeutic targetnext generationnovel therapeuticspreventtherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Autophagy is a conserved process by which all eukaryotic cells eliminate defective organelles and molecules,
and is generally regarded as a health- and longevity-promoting process. Mutations in the autophagy machinery
contribute to human conditions such as autoimmune, metabolic, inflammatory, neoplastic, and
neurodegenerative diseases, and prompt changes consistent with premature aging. Conversely, nearly all
genetic and environmental manipulations that extend lifespan do so in a manner dependent upon autophagy.
However, we have determined that autophagy has negative consequences on health when it occurs in the
setting of increased mitochondrial permeability. The net consequence of autophagy in the setting of increased
mitochondrial permeability is shortened lifespan and increased susceptibility to ischemia/reperfusion injury.
There is a critical need to understand the cellular and molecular mechanisms by which mitochondrial
permeability is regulated in order to develop the next generation of interventions to reduce negative impacts of
autophagy in aging and disease. The long-term goal of this project is to determine how mitochondrial
permeability is regulated and to define the consequences of increased mitochondrial permeability on cellular
and organismal dysfunction in aging. Our objective in this particular application is to define how upstream
signaling pathways involved in promoting longevity and reducing disease suppress mitochondrial permeability,
and the consequences this has on autophagy, mitochondrial function, and lifespan. This project will meet this
objective by studying the detailed mechanisms by which mitochondrial permeability is regulated and the
consequences of this regulation. We have determined that defects in signaling in the mTOR complex 2
pathway lead to increases in mitochondrial permeability and autophagy, shortening lifespan and increasing
ischemia/reperfusion injury. The central hypothesis of this proposal is that low mitochondrial permeability is a
central determinant of the effects of autophagy on lifespan and aging-associated diseases. The rationale for
this proposal is that fuller understanding of the regulation of mitochondrial permeability will permit us to target
permeability to promote healthy aging in humans. Guided by preliminary data, we will test our hypothesis in
three specific aims. In Aim 1, we will define the mechanisms by which mitochondrial permeability is decreased
by prolongevity pathways. In Aim 2 we will define the mechanisms by which mitochondrial permeability and
defects in mTOR complex 2 signaling drive autophagy. Aim 3 will determine the mechanism by which the union
of mitochondrial permeability and autophagy shorten lifespan. At the conclusion of these studies, we will have
identified the major mechanisms by which mitochondrial permeability disrupts cellular function and shortens
lifespan. The proposed research is significant because it will have broad implications for rational design of the
next generation of interventions that promote healthy aging through manipulation of autophagy and
mitochondrial permeability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Boston Area Diabetes and Endocrinology Research Center (BADERC)
-
批准号:10586200
-
项目类别:
-
资助金额:$109.07万
-
财政年份:2023
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Admin Core
-
批准号:10586201
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2023
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Autophagy and Mitochondrial Permeability in Aging and Longevity
-
批准号:10688322
-
项目类别:
-
资助金额:$34.44万
-
财政年份:2022
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10087180
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10264030
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10646433
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Mitochondrial action of metformin in aging and longevity
-
批准号:10432084
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
-
批准号:10371988
-
项目类别:
-
资助金额:$56.44万
-
财政年份:2017
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
-
批准号:9906124
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2017
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Epigenetic regulation of metabolism by target of rapamycin complex 2
-
批准号:8926980
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2014
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Epigenetic regulation of metabolism by target of rapamycin complex 2
-
批准号:8814823
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2014
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Dissecting the molecular mechanism of metformin action
-
批准号:8617271
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2013
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Dissecting the molecular mechanism of metformin action
-
批准号:8488698
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2013
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8704232
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8281499
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8066937
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:8486425
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics in Caenorhabditis elegans.
-
批准号:7869156
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2010
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.
-
批准号:7669330
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2007
-
负责人:ALEXANDER A SOUKAS
-
依托单位:
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.
-
批准号:7524933
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2007
-
负责人:ALEXANDER A SOUKAS
-
依托单位: